Huntsville, Alabama, September 26, 2025
News Summary
Glaukos Corporation has initiated the construction of a new research and manufacturing facility in Huntsville, Alabama, with an investment of over $80 million. Spanning 200,000 square feet on 25 acres within Cummings Research Park, it aims to create over 150 full-time jobs and bolster the local economy. The project is set for completion in 2030 and reflects Glaukos’ commitment to healthcare innovation, particularly in developing therapies for eye disorders.
Huntsville, Alabama – Glaukos Corporation, an ophthalmic pharmaceutical and medical technology company, has officially broken ground on its new research and manufacturing facility in Huntsville. This significant development represents an investment exceeding $80 million and aims to bolster the region’s economic landscape through job creation and technological innovation.
The new facility will encompass 200,000 square feet and will be located on 25 acres in Cummings Research Park, a hub designed to attract companies focused on advancing human health and medical solutions. Additionally, there is an optional agreement in place for an extra 15 acres, allowing for potential future expansion as Glaukos grows its operations.
Once completed, expected in 2030, the facility is projected to generate more than 150 full-time jobs in the Huntsville area. This move is part of Glaukos’ long-term growth strategy, which includes developing innovative therapies for various eye disorders such as glaucoma, corneal disorders, and retinal diseases.
Thomas Burns, Glaukos’ chairman and CEO, reinforced the company’s commitment to enhancing U.S. manufacturing and promoting healthcare innovation through this multi-million dollar investment. Huntsville was selected for the new site after an extensive evaluation of over 100 potential sites worldwide, indicating the city’s strong talent pool and favorable business climate played crucial roles in the decision-making process.
The groundbreaking ceremony attracted notable attendees, including U.S. Representatives Dale Strong and Robert Aderholt, along with Huntsville Mayor Tommy Battle and local officials. Congressman Strong expressed pride in Glaukos’ commitment to the local community and its potential impact on improving patient outcomes. Mayor Battle acknowledged the supportive environment for science and technology in Huntsville, suggesting Glaukos’ investment is a validation of the city’s strengths.
Glaukos is well known for pioneering Micro-Invasive Glaucoma Surgery (MIGS) and for recently launching the iDose TR therapeutic product for glaucoma treatment. The company’s headquarters are situated in Aliso Viejo, California, with additional facilities in San Clemente, California, and Burlington, Massachusetts. The recent development is expected to act as a significant economic driver for the Huntsville region and symbolizes a resurgence in U.S. manufacturing leadership.
The Cummings Research Park where Glaukos’ facility will be located serves as a strategic base for companies dedicated to advancing healthcare solutions, thereby enhancing the overall capabilities of the region in the biomedical and pharmaceutical sectors.
Key Features of Glaukos’ Facility
| Feature | Description |
|---|---|
| Investment | $80 million |
| Facility Size | 200,000 square feet |
| Site Area | 25 acres (with an optional 15 acres for expansion) |
| Job Creation | 150+ full-time jobs |
| Completion Date | 2030 |
| Location | Cummings Research Park, Huntsville, Alabama |
FAQs
What is Glaukos Corporation developing in Huntsville, Alabama?
What is the investment amount for the new Glaukos facility?
How large will the new facility be?
When is the completion of the new Glaukos facility expected?
How many jobs will the facility create?
What technologies and therapies will the facility support?
Deeper Dive: News & Info About This Topic
HERE Resources
Huntsville and Auburn/Opelika Recognized for Economic Development Excellence
Explosion Rocks Madison County: Investigation Underway
Spring Learning Opportunities in Huntsville
Additional Resources
- Investing.com: Glaukos Breaks Ground on $80 Million Facility in Huntsville
- Wikipedia: Glaukos Corporation
- AL.com: Pharmaceutical Giant Chooses to Invest $82 Million in Huntsville Facility
- Google Search: Glaukos Corporation
- Huntsville Business Journal: Glaukos Corporation Sees a Bright Future in Huntsville
- Encyclopedia Britannica: Medical Technology
- WAFF: Glaukos Bringing More Than 150 Jobs to Cummings Research Park
- Google News: Huntsville Alabama
Author: STAFF HERE HUNTSVILLE WRITER
The HUNTSVILLE STAFF WRITER represents the experienced team at HEREHuntsville.com, your go-to source for actionable local news and information in Huntsville, Madison County, and beyond. Specializing in "news you can use," we cover essential topics like product reviews for personal and business needs, local business directories, politics, real estate trends, neighborhood insights, and state news affecting the area—with deep expertise drawn from years of dedicated reporting and strong community input, including local press releases and business updates. We deliver top reporting on high-value events such as Panoply Arts Festival, Rocket City Brewfest, and Huntsville Comic & Pop Culture Expo. Our coverage extends to key organizations like the Huntsville/Madison County Chamber of Commerce and HudsonAlpha Institute for Biotechnology, plus leading businesses in aerospace, defense, and manufacturing that power the local economy such as Boeing, SAIC, and Mazda Toyota Manufacturing. As part of the broader HERE network, including HEREBirmingham.com, we provide comprehensive, credible insights into Alabama's dynamic landscape.
